Tokyo Tape
Sign in
← CellSeed

Annual report

7776.TEDINET S100QIL1
Period2022-01-01 → 2022-12-31
Filed2023-03-31
StandardJapan GAAP
ConsolidatedNo
Data checks9 of 12 passed
Key figures · 110
MetricValuePeriodScopeSource row
Revenue¥126m2022-01-01 → 2022-12-31StandaloneNet sales
Revenue¥162m2021-01-01 → 2021-12-31StandaloneNet sales
Revenue¥199m2020-01-01 → 2020-12-31dStandaloneNet sales (5-year summary)
Revenue¥276m2019-01-01 → 2019-12-31dStandaloneNet sales (5-year summary)
Revenue¥1.0bn2018-01-01 → 2018-12-31dStandaloneNet sales (5-year summary)
Operating income−¥743m2022-01-01 → 2022-12-31StandaloneOperating income
Operating income−¥864m2021-01-01 → 2021-12-31StandaloneOperating income
Ordinary income−¥754m2022-01-01 → 2022-12-31StandaloneOrdinary income
Ordinary income−¥866m2021-01-01 → 2021-12-31StandaloneOrdinary income
Ordinary income−¥887m2021-01-01 → 2021-12-31StandaloneOrdinary income loss (5-year summary)
Ordinary income−¥745m2020-01-01 → 2020-12-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income−¥729m2020-01-01 → 2020-12-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income−¥786m2019-01-01 → 2019-12-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income−¥787m2019-01-01 → 2019-12-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income¥141m2018-01-01 → 2018-12-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income¥141m2018-01-01 → 2018-12-31dStandaloneOrdinary income loss (5-year summary)
Profit before tax−¥759m2022-01-01 → 2022-12-31StandaloneIncome before income taxes
Profit before tax−¥909m2021-01-01 → 2021-12-31StandaloneIncome before income taxes
Net income (owners)−¥915m2021-01-01 → 2021-12-31StandaloneProfit loss attributable to owners of parent (5-year summary)
Net income (owners)−¥784m2020-01-01 → 2020-12-31dStandaloneProfit loss attributable to owners of parent (5-year summary)
Net income (owners)−¥782m2019-01-01 → 2019-12-31dStandaloneProfit loss attributable to owners of parent (5-year summary)
Net income (owners)¥130m2018-01-01 → 2018-12-31dStandaloneProfit loss attributable to owners of parent (5-year summary)
Net income−¥760m2022-01-01 → 2022-12-31StandaloneProfit loss
Net income−¥913m2021-01-01 → 2021-12-31StandaloneProfit loss
Net income−¥768m2020-01-01 → 2020-12-31dStandaloneNet income loss (5-year summary)
Net income−¥783m2019-01-01 → 2019-12-31dStandaloneNet income loss (5-year summary)
Net income¥130m2018-01-01 → 2018-12-31dStandaloneNet income loss (5-year summary)
Total assets¥1.5bnat 2022-12-31StandaloneAssets
Total assets¥1.4bnat 2021-12-31StandaloneAssets
Total assets¥1.4bnat 2021-12-31StandaloneTotal assets (5-year summary)
Total assets¥1.8bnat 2020-12-31dStandaloneTotal assets (5-year summary)
Total assets¥1.8bnat 2020-12-31dStandaloneTotal assets (5-year summary)
Total assets¥1.5bnat 2019-12-31dStandaloneTotal assets (5-year summary)
Total assets¥1.5bnat 2019-12-31dStandaloneTotal assets (5-year summary)
Total assets¥1.6bnat 2018-12-31dStandaloneTotal assets (5-year summary)
Total assets¥1.6bnat 2018-12-31dStandaloneTotal assets (5-year summary)
Total liabilities¥366mat 2022-12-31StandaloneLiabilities
Total liabilities¥364mat 2021-12-31StandaloneLiabilities
Net assets / equity¥1.2bnat 2022-12-31StandaloneNet assets
Net assets / equity¥1.0bnat 2021-12-31StandaloneNet assets
Net assets / equity¥1.0bnat 2021-12-31StandaloneNet assets (5-year summary)
Net assets / equity¥1.6bnat 2020-12-31dStandaloneNet assets
Net assets / equity¥1.5bnat 2020-12-31dStandaloneNet assets (5-year summary)
Net assets / equity¥1.3bnat 2019-12-31dStandaloneNet assets (5-year summary)
Net assets / equity¥1.4bnat 2019-12-31dStandaloneNet assets (5-year summary)
Net assets / equity¥1.4bnat 2018-12-31dStandaloneNet assets (5-year summary)
Net assets / equity¥1.4bnat 2018-12-31dStandaloneNet assets (5-year summary)
Cash and deposits¥1.1bnat 2022-12-31StandaloneCash and deposits
Cash and deposits¥847mat 2021-12-31StandaloneCash and deposits
Cash & equivalents¥1.1bnat 2022-12-31StandaloneCash and cash equivalents
Cash & equivalents¥847mat 2021-12-31StandaloneCash and cash equivalents
Cash & equivalents¥931mat 2021-12-31StandaloneCash and cash equivalents (5-year summary)
Cash & equivalents¥1.5bnat 2020-12-31dStandaloneCash and cash equivalents (5-year summary)
Cash & equivalents¥1.1bnat 2019-12-31dStandaloneCash and cash equivalents (5-year summary)
Cash & equivalents¥1.1bnat 2018-12-31dStandaloneCash and cash equivalents (5-year summary)
Operating cash flow−¥718m2022-01-01 → 2022-12-31StandaloneNet cash provided by used in operating activities
Operating cash flow−¥817m2021-01-01 → 2021-12-31StandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow−¥701m2020-01-01 → 2020-12-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow−¥578m2019-01-01 → 2019-12-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow−¥307m2018-01-01 → 2018-12-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Investing cash flow¥62m2022-01-01 → 2022-12-31StandaloneNet cash provided by used in investment activities
Investing cash flow−¥110m2021-01-01 → 2021-12-31StandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow−¥13m2020-01-01 → 2020-12-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow−¥133m2019-01-01 → 2019-12-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow−¥1m2018-01-01 → 2018-12-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Financing cash flow¥882m2022-01-01 → 2022-12-31StandaloneNet cash provided by used in financing activities
Financing cash flow¥397m2021-01-01 → 2021-12-31StandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow¥1.1bn2020-01-01 → 2020-12-31dStandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow¥721m2019-01-01 → 2019-12-31dStandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow¥25m2018-01-01 → 2018-12-31dStandaloneNet cash provided by used in financing activities (5-year summary)
EPS (basic)¥-36.312022-01-01 → 2022-12-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-53.182021-01-01 → 2021-12-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-53.082021-01-01 → 2021-12-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-55.312020-01-01 → 2020-12-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-54.192020-01-01 → 2020-12-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-66.62019-01-01 → 2019-12-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-66.682019-01-01 → 2019-12-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥11.352018-01-01 → 2018-12-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥11.382018-01-01 → 2018-12-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (diluted)¥11.272018-01-01 → 2018-12-31dStandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥11.32018-01-01 → 2018-12-31dStandaloneDiluted earnings per share (5-year summary)
Net assets per share¥47.26at 2022-12-31StandaloneNet assets per share (5-year summary)
Net assets per share¥56.44at 2021-12-31StandaloneNet assets per share (5-year summary)
Net assets per share¥57.43at 2021-12-31StandaloneNet assets per share (5-year summary)
Net assets per share¥93.85at 2020-12-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥95.7at 2020-12-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥102.24at 2019-12-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥103.88at 2019-12-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥121.19at 2018-12-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥122.78at 2018-12-31dStandaloneNet assets per share (5-year summary)
Equity ratio74.8%at 2022-12-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio72.0%at 2021-12-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio72.4%at 2021-12-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio83.2%at 2020-12-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio83.5%at 2020-12-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio91.1%at 2019-12-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio91.3%at 2019-12-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio87.5%at 2018-12-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio87.3%at 2018-12-31dStandaloneEquity to asset ratio (5-year summary)
ROE9.8%2018-01-01 → 2018-12-31dStandaloneRate of return on equity (5-year summary)
Shares issued24,422,619at 2022-12-31StandaloneTotal number of issued shares (5-year summary)
Shares issued17,759,419at 2021-12-31StandaloneTotal number of issued shares (5-year summary)
Shares issued16,008,319at 2020-12-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued12,981,819at 2019-12-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued11,459,419at 2018-12-31dStandaloneTotal number of issued shares (5-year summary)
Employees30at 2022-12-31StandaloneNumber of employees
Employees44at 2021-12-31StandaloneNumber of employees
Employees40at 2020-12-31dStandaloneNumber of employees
Employees40at 2019-12-31dStandaloneNumber of employees
Employees39at 2018-12-31dStandaloneNumber of employees

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 21
SegmentItemPeriodValue
Reconciling Itemsreconcilingcapex2022-01-01 → 2022-12-31¥3m
Reconciling Itemsreconcilingsegment assetsat 2022-12-31¥1.3bn
Reconciling Itemsreconcilingsegment profit2022-01-01 → 2022-12-31−¥190m
Cell Sheet Regenerative Medicinereportable segmentemployeesat 2022-12-3119 pure
Cell Sheet Regenerative Medicinereportable segmentrevenue2022-01-01 → 2022-12-31¥10m
Cell Sheet Regenerative Medicinereportable segmentrevenue external2022-01-01 → 2022-12-31¥10m
Cell Sheet Regenerative Medicinereportable segmentsegment assetsat 2022-12-31¥82m
Cell Sheet Regenerative Medicinereportable segmentsegment profit2022-01-01 → 2022-12-31−¥463m
Laboratory Consumables And Equipmentreportable segmentcapex2022-01-01 → 2022-12-31¥563,000
Laboratory Consumables And Equipmentreportable segmentdepreciation2022-01-01 → 2022-12-31¥8m
Laboratory Consumables And Equipmentreportable segmentemployeesat 2022-12-317 pure
Laboratory Consumables And Equipmentreportable segmentrevenue2022-01-01 → 2022-12-31¥116m
Laboratory Consumables And Equipmentreportable segmentrevenue external2022-01-01 → 2022-12-31¥116m
Laboratory Consumables And Equipmentreportable segmentsegment assetsat 2022-12-31¥196m
Laboratory Consumables And Equipmentreportable segmentsegment profit2022-01-01 → 2022-12-31−¥90m
—segment totalcapex2022-01-01 → 2022-12-31¥563,000
—segment totaldepreciation2022-01-01 → 2022-12-31¥8m
—segment totalrevenue2022-01-01 → 2022-12-31¥126m
—segment totalrevenue external2022-01-01 → 2022-12-31¥126m
—segment totalsegment assetsat 2022-12-31¥277m
—segment totalsegment profit2022-01-01 → 2022-12-31−¥553m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 895
ItemContextValueUnit
LiabilitiesPrior1YearInstant_NonConsolidatedMember363581000JPY
LiabilitiesCurrentYearInstant_NonConsolidatedMember365582000JPY
Capital stockPrior1YearInstant_NonConsolidatedMember4548657000JPY
Capital stockCurrentYearInstant_NonConsolidatedMember1467377000JPY
Legal capital surplusPrior1YearInstant_NonConsolidatedMember1770454000JPY
Legal capital surplusCurrentYearInstant_NonConsolidatedMember446957000JPY
Capital surplusPrior1YearInstant_NonConsolidatedMember1770454000JPY
Capital surplusCurrentYearInstant_NonConsolidatedMember446957000JPY
Retained earnings brought forwardPrior1YearInstant_NonConsolidatedMember-5298692000JPY
Retained earnings brought forwardCurrentYearInstant_NonConsolidatedMember-759680000JPY
Retained earningsPrior1YearInstant_NonConsolidatedMember-5298692000JPY
Retained earningsCurrentYearInstant_NonConsolidatedMember-759680000JPY
Treasury stockPrior1YearInstant_NonConsolidatedMember-227000JPY
Treasury stockCurrentYearInstant_NonConsolidatedMember-227000JPY
Shareholders equityPrior1YearInstant_NonConsolidatedMember1020191000JPY
Shareholders equityCurrentYearInstant_NonConsolidatedMember1154427000JPY
Valuation difference on available for sale securitiesPrior1YearInstant_NonConsolidatedMember-321000JPY
Valuation difference on available for sale securitiesCurrentYearInstant_NonConsolidatedMember-321000JPY
Valuation and translation adjustmentsPrior1YearInstant_NonConsolidatedMember-321000JPY
Valuation and translation adjustmentsCurrentYearInstant_NonConsolidatedMember-321000JPY
Subscription rights to sharesPrior1YearInstant_NonConsolidatedMember24757000JPY
Subscription rights to sharesCurrentYearInstant_NonConsolidatedMember24232000JPY
Net assetsPrior1YearInstant_NonConsolidatedMember1044627000JPY
Net assetsCurrentYearInstant_NonConsolidatedMember1178338000JPY
Liabilities and net assetsPrior1YearInstant_NonConsolidatedMember1408209000JPY
Liabilities and net assetsCurrentYearInstant_NonConsolidatedMember1543920000JPY
Net salesPrior1YearDuration_NonConsolidatedMember161673000JPY
Net salesCurrentYearDuration_NonConsolidatedMember126427000JPY
Beginning merchandise and finished goods cosPrior1YearDuration_NonConsolidatedMember15304000JPY
Beginning merchandise and finished goods cosCurrentYearDuration_NonConsolidatedMember24315000JPY
Cost of purchased goodsPrior1YearDuration_NonConsolidatedMember15583000JPY
Cost of purchased goodsCurrentYearDuration_NonConsolidatedMember17749000JPY
Cost of products manufacturedPrior1YearDuration_NonConsolidatedMember75669000JPY
Cost of products manufacturedCurrentYearDuration_NonConsolidatedMember46396000JPY
Total beginning and purchase of goodsPrior1YearDuration_NonConsolidatedMember106556000JPY
Total beginning and purchase of goodsCurrentYearDuration_NonConsolidatedMember88461000JPY
Transfer to other account cosPrior1YearDuration_NonConsolidatedMember4605000JPY
Transfer to other account cosCurrentYearDuration_NonConsolidatedMember3295000JPY
Ending merchandise and finished goods cosPrior1YearDuration_NonConsolidatedMember24315000JPY
Ending merchandise and finished goods cosCurrentYearDuration_NonConsolidatedMember19757000JPY
Cost of salesPrior1YearDuration_NonConsolidatedMember77635000JPY
Cost of salesCurrentYearDuration_NonConsolidatedMember65408000JPY
Gross profitPrior1YearDuration_NonConsolidatedMember84038000JPY
Gross profitCurrentYearDuration_NonConsolidatedMember61019000JPY
Research and development expenses sgaPrior1YearDuration_NonConsolidatedMember541241000JPY
Research and development expenses sgaCurrentYearDuration_NonConsolidatedMember444759000JPY
Other sgaPrior1YearDuration_NonConsolidatedMember406904000JPY
Other sgaCurrentYearDuration_NonConsolidatedMember359474000JPY
Selling general and administrative expensesPrior1YearDuration_NonConsolidatedMember948145000JPY
Selling general and administrative expensesCurrentYearDuration_NonConsolidatedMember804234000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 9 of 12 passed
balance sheet identitynon_consolidated 2021-12-31pass rounding
balance sheet identitynon_consolidated 2022-12-31pass
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2020-12-31mismatch
statement vs summary · net assetsnon_consolidated 2021-12-31mismatch
statement vs summary · net assetsnon_consolidated 2022-12-31pass
statement vs summary · operating cash flownon_consolidated 2022-01-01/2022-12-31pass
statement vs summary · revenuenon_consolidated 2021-01-01/2021-12-31pass
statement vs summary · revenuenon_consolidated 2022-01-01/2022-12-31pass
statement vs summary · total assetsnon_consolidated 2021-12-31mismatch
statement vs summary · total assetsnon_consolidated 2022-12-31pass